COMMUNIQUÉS West-GlobeNewswire

Inovio Pharmaceuticals to Participate in Upcoming Investment Conferences
21/08/2018
PLYMOUTH MEETING, Pa., Aug. 21, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced that the Company will participate in the following upcoming investment conferences: Rodman and Renshaw [...]
Biotricity Expands Salesforce to Cover Key US Markets and Begins Advisory Board Expansion to Move Into Preemptive Heart Disease Diagnostics
21/08/2018
The Company has Expanded its Sales Team to Cover Two Additional Geographic Centers in the US REDWOOD CITY, Calif., Aug. 21, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer [...]
Eyenovia to Present at the 20th Annual H.C. Wainwright Global Investment Conference
21/08/2018
NEW YORK, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to deliver microdosed [...]
VitalHub Announces Sale of TREAT EHR System to Youth Mental Health Facility
21/08/2018
TORONTO, Aug. 21, 2018 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company”) (TSXV: VHI) is pleased to announce the sale of the TREAT EHR solution (“TREAT”) to Stella’s Place, a Toronto-based young adult mental health [...]
Aclaris Therapeutics Announces ATI-450 (MK2 pathway Inhibitor) publication in the Journal Cancer Research
21/08/2018
WAYNE, Pa., Aug. 21, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative therapies to [...]
Tonix Pharmaceuticals Presents Results and Retrospective Analyses of Two Double-Blind, Randomized Placebo-Controlled 12-Week Studies of Tonmya® in Military-Related PTSD at the 2018 Military Health System Research Symposium
21/08/2018
Retrospective Analysis of the Discontinued Phase 3 P301 “HONOR” Study Revealed Clinically Meaningful Response to Tonmya in PTSD Participants with Trauma Experienced Within Nine Years Prior to Screening but Not in [...]
Auxly Announces Acquisition of Leading Canadian Contract Research Organization KGK Science
21/08/2018
VANCOUVER, British Columbia, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") is pleased to announce that it has entered into a share purchase agreement (the “ [...]
Capricor Therapeutics Presents Results of Studies of CAP-2003 at Gordon Research Conference on Extracellular Vesicles
21/08/2018
Research Demonstrates the Investigational Therapy’s Mechanism of Action and Immunomodulatory Capacities LOS ANGELES, Aug. 21, 2018 (GLOBE NEWSWIRE) -- At the Gordon Research Conference on Extracellular Vesicles in Newry [...]
PetVivo Holdings, Inc. Adds Three New Board Members
21/08/2018
MINNEAPOLIS, Aug. 21, 2018 (GLOBE NEWSWIRE) -- (OTCMARKET:PETV), PetVivo Holdings, Inc. ( www.petvivo.com ), an emerging biomedical device company, is pleased to announce the addition of Ms. Sherry Grisewood CFA, Mr. [...]
International Stem Cell Corporation Granted Key US Patent Protecting Lead Therapeutic Program
21/08/2018
CARLSBAD, Calif., Aug. 21, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB: ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company [...]
Aptinyx Presents Preclinical Data from Fast-Track Designated PTSD Program at Military Health System Research Symposium
21/08/2018
EVANSTON, Ill., Aug. 21, 2018 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ:APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today [...]
Emblem enters into a supply agreement with operator of the Ontario Cannabis Store for high quality, Ontario-grown cannabis
21/08/2018
Emblem selected as one of 26 licensed producers to supply Ontario for adult-use market PARIS, Ontario, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (TSXV:EMC.WT) (“Emblem” or the "Company") is pleased to [...]
Achillion Appoints Dr. Steven Zelenkofske as Chief Medical Officer and Further Strengthens Clinical Development Team
21/08/2018
NEW HAVEN, Conn., Aug. 21, 2018 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) today announced the appointment of Steven Zelenkofske, D.O. to the position of Executive Vice President and Chief [...]
Genetic Technologies Limited Invited by Representatives of the Hainan Government to Discuss Market Entry into China
21/08/2018
MELBOURNE, Australia, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Representatives of the Hainan Government - Hainan Ecological Smart City Group (“ HESCG ”), a Chinese industrial park development & operations company have [...]
Transactions in relation to share buyback program
21/08/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Immutep Receives A$1.9 Million Research and Development Related Tax Rebate from French Government
21/08/2018
SYDNEY, Australia, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune [...]
Correction of geographical distribution in C-RAD ABs Interim report January-June 2018
21/08/2018
Correction of geographical distribution in C-RAD ABs Interim report January-June 2018 In C-RADs Interim Report for January – June, 2018 it has been identified that the figures in a graph of the geographical distribution [...]
Solon Eiendom ASA – Primary insider notification
21/08/2018
(Oslo, Norway, August 20, 2018) UFI AS has today extended TRS agreements relating to 2 385 808 shares in Solon Eiendom ASA. The new expiration of the TRS agreements are November 16, 2018 and the exercise price is NOK 26 [...]
Acarix Interim Report, January - June 2018 : Acarix gains traction in key markets providing physicians and patients new opportunities
21/08/2018
Interim Report, January - June 2018 Malmö, August 21, 2018 Acarix gains traction in key markets providing physicians and patients new opportunities "Since the inception of Acarix, the company has been fully committed to [...]

Pages